Astellas Pharma Inc.

Astellas Pharma Inc.

ALPMY
Astellas Pharma Inc.US flagOther OTC
13.40
USD
-0.20
- -
24.01BMarket Cap

Astellas Pharma Inc. (ALPMY) Stock Splits

Learn about Astellas Pharma Inc.'s most recent 5-for-4 basis stock split on April 02, 2014. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Astellas Pharma Inc.'s most recent stock split

Split Date: 2014-04-02
Split Ratio: 5:4
Price Before Split: $14.75
Price After Split: $11.80

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.25 times more shares (a 5:4 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Astellas Pharma Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2014-04-025:4No$14.75$11.80
2013-05-134:1No$54.60$13.65

About Astellas Pharma Inc.

Company overview and industry information

Astellas Pharma Inc. (ALPMY) operates in the Drug Manufacturers - General industry. The recent 5-for-4 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - General
Go to Astellas Pharma Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.